These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6532472)

  • 41. Spectrum of autoantibodies for gastrointestinal autoimmune diseases in systemic lupus erythematosus patients.
    Picceli VF; Skare TL; Nisihara R; Kotze L; Messias-Reason I; Utiyama SR
    Lupus; 2013 Oct; 22(11):1150-5. PubMed ID: 24057059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enzyme-linked immunosorbent assay (ELISA) for detection of antibodies against glycosphingolipids and its application to patients with systemic lupus erythematosus.
    Sanai Y; Ogawa J; Nagai Y
    Jpn J Exp Med; 1981 Oct; 51(5):309-16. PubMed ID: 7321255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The mechanism of autoimmune cutaneous diseases].
    Jablonska S; Chorzelski T
    Ann Dermatol Syphiligr (Paris); 1971; 98(4):377-92. PubMed ID: 4945246
    [No Abstract]   [Full Text] [Related]  

  • 44. New conceptions of autoimmunity and of systemic lupus erythematosus.
    Bach JF; Bach MA; Tron F
    Adv Nephrol Necker Hosp; 1976; 6():5-35. PubMed ID: 139083
    [No Abstract]   [Full Text] [Related]  

  • 45. Reduction of acute graft-versus-host disease-related mortality and cytotoxic T lymphocyte induction after pretreatment of the recipient with anti-asialo GM1 antibody in the murine P-to-F1 model.
    Varkila K; Hurme M
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2690-1. PubMed ID: 3274580
    [No Abstract]   [Full Text] [Related]  

  • 46. Inability of anti-asialo-GM1 and 2-chloroadenosine to abrogate maleic anhydride-divinyl ether-induced resistance against experimental murine lung carcinoma metastases.
    Schultz RM; Tang JC; DeLong DC; Ades EW; Altom MG
    Cancer Res; 1986 Nov; 46(11):5624-8. PubMed ID: 3756909
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synergistic defense system by cooperative natural effectors against metastasis of B16 melanoma cells in H-2-associated control: different behavior of H-2+ and H-2- cells in metastatic processes.
    Kawano Y; Taniguchi K; Toshitani A; Nomoto K
    J Immunol; 1986 Jun; 136(12):4729-34. PubMed ID: 3711664
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Suppression of pulmonary tumour metastasis in mice by recombinant human interleukin-2: role of asialo GM1-positive cells.
    Hinuma S; Naruo K; Ootsu K; Houkan T; Shiho O; Tsukamoto K
    Immunology; 1987 Feb; 60(2):173-9. PubMed ID: 3493209
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Production and characterization of a mouse monoclonal antibody to the glycolipid asialo-GM1.
    Jacquemart F; Millot G; Goujet-Zalc C; Mahouy G; Zalc B
    Hybridoma; 1988 Aug; 7(4):323-31. PubMed ID: 3169804
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
    Stitz L; Baenziger J; Pircher H; Hengartner H; Zinkernagel RM
    J Immunol; 1986 Jun; 136(12):4674-80. PubMed ID: 3486908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Detection of immune globulin and autoantibodies in autoimmune diseases, with special reference to SLE and Hashimoto's diseases].
    Ofumi T; Morita M; Sato H; Miyawaki S; Yamana S
    Naika; 1968 Dec; 22(7):1571-9. PubMed ID: 4180449
    [No Abstract]   [Full Text] [Related]  

  • 52. [Antibodies to extractable nuclear antigens in systemic lupus erythematosus].
    Ivanova SM; Alekberova ZS; Preobrazhenskiĭ DV; Speranskiĭ AI
    Ter Arkh; 1982; 54(6):54-7. PubMed ID: 7112420
    [No Abstract]   [Full Text] [Related]  

  • 53. Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases.
    Yamasaki Y; Narain S; Hernandez L; Barker T; Ikeda K; Segal MS; Richards HB; Chan EK; Reeves WH; Satoh M
    Arthritis Res Ther; 2006; 8(4):R111. PubMed ID: 16846524
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Experimental autoimmunity.
    Nussenblatt RB; Gunn HC; Ryffel B; Borel JF
    Prog Allergy; 1986; 38():159-80. PubMed ID: 3487790
    [No Abstract]   [Full Text] [Related]  

  • 55. Relative paradigms between autoantibodies in lupus and autoantibodies in cancer.
    Tan EM; Shi FD
    Clin Exp Immunol; 2003 Nov; 134(2):169-77. PubMed ID: 14616773
    [No Abstract]   [Full Text] [Related]  

  • 56. Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE).
    Asherson RA; Denburg SD; Denburg JA; Carbotte RM; Futrell N
    Postgrad Med J; 1993 Aug; 69(814):602-8. PubMed ID: 8234102
    [No Abstract]   [Full Text] [Related]  

  • 57. [Autoimmune diseases].
    Deuel W; Siegenthaler-Zuber G; Siegenthaler W
    Schweiz Rundsch Med Prax; 1988 May; 77(18):485-8. PubMed ID: 3051259
    [No Abstract]   [Full Text] [Related]  

  • 58. Expression of asialo GM1 by both Thy-1-positive and Thy-1-negative lymphocytes: evidence for modification of asialo GM1 by sialic acid.
    Harris MT; Schwarting GA; Stout RD
    Thymus; 1981 Sep; 3(3):169-84. PubMed ID: 6171919
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Measles antibodies in sera from patients with autoimmune diseases.
    Lucas CJ; Brouwer R; Feltkamp TE; ten Veen JH; van Loghem JJ
    Lancet; 1972 Jan; 1(7742):115-6. PubMed ID: 4108981
    [No Abstract]   [Full Text] [Related]  

  • 60. Heterospecific anti-nucleoprotein activity of murine lupus erythematosus cell factor.
    Sharard A
    Am J Clin Pathol; 1968 Jul; 50(1):98. PubMed ID: 5659286
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.